Sight Sciences, Inc. (SGHT) Income Statement
SGHT 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSGHT revenue and net income
Where SGHT's revenue goes
2025Each bar shows an amount and its share of revenue. SGHT kept −49.7% of revenue as net income.
SGHT profit margins
SGHT growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −3.1% | +2.7% | +22.9% | — |
| Gross profit | −2.4% | +4.2% | +29.3% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SGHT quarterly EPS vs estimates
Sight Sciences beat the analyst EPS estimate in 4 of the last 8 quarters. Next report: November 5, 2026 (estimate $-0.13).
SGHT income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $77.4M | $79.9M | $81.1M | $71.3M | $49.0M | $27.6M | $23.3M | $7.5M |
| Cost of revenue | $10.7M | $11.6M | $11.9M | $12.4M | $8.6M | $9.2M | $6.5M | $2.3M |
| Gross profit | $66.7M | $68.3M | $69.2M | $59.0M | $40.3M | $18.4M | $16.8M | $5.2M |
| Research & development | $14.6M | $18.0M | $17.6M | $22.9M | $15.6M | $8.9M | $8.1M | $5.4M |
| Sales, general & admin | $89.2M | $100.8M | $108.9M | $120.1M | $76.2M | $41.7M | $32.7M | $14.1M |
| Total operating expenses | $103.8M | $118.8M | $126.4M | $142.9M | $91.8M | $50.6M | $40.8M | $19.5M |
| Operating income | −$37.1M | −$50.5M | −$57.3M | −$84.0M | −$51.5M | −$32.2M | −$24.0M | −$14.3M |
| Interest income | — | — | — | — | $0 | $30,000 | $174,000 | $1,000 |
| Interest expense | $5.1M | $4.7M | $5.4M | $4.5M | $4.4M | $2.4M | $2.0M | $0 |
| Income before taxes | −$38.4M | −$51.3M | −$55.4M | −$86.2M | −$62.8M | −$34.6M | −$25.9M | −$14.3M |
| Income taxes | $10,000 | $236,000 | $110,000 | $47,000 | $188,000 | $61,000 | $8,000 | −$6,000 |
| Net income | −$38.4M | −$51.5M | −$55.5M | −$86.2M | −$63.0M | −$34.7M | −$25.9M | −$14.3M |
| EBITDA | −$32.8M | −$45.9M | −$49.4M | −$81.0M | −$57.2M | −$31.7M | −$23.5M | −$14.2M |
| EPS (diluted) | −$0.75 | −$0.99 | −$1.14 | −$1.80 | −$3.89 | −$2.57 | −$1.94 | — |
| Gross margin | 86.2% | 85.5% | 85.3% | 82.7% | 82.4% | 66.7% | 72.0% | 69.0% |
| Operating margin | −48.0% | −63.3% | −70.7% | −117.7% | −105.2% | −116.5% | −103.0% | −189.9% |
| Net margin | −49.7% | −64.5% | −68.5% | −120.9% | −128.6% | −125.5% | −110.8% | −189.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.4M | $19.7M | $20.4M | $19.9M | $19.6M | $17.5M | $19.1M | $20.2M | $21.4M | $19.3M | $18.8M | $20.0M |
| Cost of revenue | $2.0M | $2.7M | $2.6M | $2.7M | $3.0M | $2.4M | $2.5M | $3.2M | $3.0M | $2.8M | $2.8M | $2.7M |
| Gross profit | $21.4M | $17.0M | $17.8M | $17.2M | $16.6M | $15.1M | $16.6M | $16.9M | $18.3M | $16.5M | $16.0M | $17.3M |
| Research & development | $2.5M | $2.5M | $2.4M | $3.4M | $4.4M | $4.4M | $4.3M | $4.7M | $4.3M | $4.6M | $3.4M | $4.2M |
| Sales, general & admin | $22.8M | $26.8M | $19.0M | $21.8M | $23.9M | $24.5M | $24.2M | $23.4M | $26.7M | $26.6M | $23.7M | $26.5M |
| Total operating expenses | $25.3M | $29.4M | $21.5M | $25.1M | $28.3M | $29.0M | $28.5M | $28.1M | $31.0M | $31.2M | $27.1M | $30.7M |
| Operating income | −$3.9M | −$12.4M | −$3.7M | −$7.9M | −$11.7M | −$13.9M | −$11.9M | −$11.2M | −$12.7M | −$14.7M | −$11.1M | −$13.4M |
| Interest expense | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.2M | $1.2M | $1.1M | $1.2M | $1.4M | $1.4M |
| Income before taxes | −$4.4M | −$13.0M | −$4.2M | −$8.2M | −$11.9M | −$14.1M | −$11.8M | −$10.9M | −$12.3M | −$16.2M | −$10.7M | −$13.0M |
| Income taxes | $28,000 | $11,000 | $8,000 | −$79,000 | $40,000 | $41,000 | $38,000 | $166,000 | $15,000 | $17,000 | $10,000 | $78,000 |
| Net income | −$4.4M | −$13.0M | −$4.2M | −$8.2M | −$11.9M | −$14.2M | −$11.8M | −$11.1M | −$12.3M | −$16.3M | −$10.7M | −$13.0M |
| EBITDA | −$4.6M | −$11.6M | −$2.8M | −$6.8M | −$10.5M | −$12.7M | −$10.5M | −$9.6M | −$11.1M | −$14.9M | −$9.1M | −$11.4M |
| EPS (diluted) | −$0.08 | −$0.24 | −$0.08 | −$0.16 | −$0.23 | −$0.28 | −$0.23 | −$0.22 | −$0.25 | −$0.29 | −$0.22 | −$0.27 |
| Gross margin | 91.4% | 86.2% | 87.3% | 86.4% | 84.8% | 86.2% | 86.8% | 83.9% | 85.8% | 85.5% | 85.2% | 86.6% |
| Operating margin | −16.6% | −63.0% | −18.0% | −39.7% | −59.6% | −79.2% | −62.5% | −55.7% | −59.2% | −76.4% | −59.3% | −67.0% |
| Net margin | −19.0% | −65.9% | −20.4% | −41.0% | −61.0% | −80.8% | −62.1% | −54.9% | −57.7% | −84.4% | −57.0% | −65.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SGHT's financial statements (latest annual report filed March 4, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SGHT financial results
In fiscal year 2025 (ended December 31, 2025), Sight Sciences reported revenue of $77.4 million, down 3.1% from the year before. It had a net loss of $38.4 million, a net profit margin of −49.7%. Diluted earnings per share came to −$0.75. Over five years revenue grew at an average rate of 22.9% a year.
See the SGHT stock overview for the latest quote and news, or the SGHT chart for price history and technical indicators.
SGHT income statement FAQ
What is Sight Sciences's annual revenue?
Sight Sciences reported total revenue of $77.4 million for fiscal year 2025, which ended on December 31, 2025. That was down 3.1% from $79.9 million the previous year.
Is Sight Sciences profitable?
No. Sight Sciences reported a net loss of $38.4 million in fiscal 2025, a net profit margin of −49.7%; its operating margin was −48.0%.
What is Sight Sciences's gross margin?
Sight Sciences's gross margin was 86.2% in fiscal 2025: for every $100 of revenue, Sight Sciences kept $86 after the direct cost of its products and services.
How much does Sight Sciences spend on research and development?
Sight Sciences spent $14.6 million on research and development in fiscal 2025, 18.9% of revenue.
How fast is Sight Sciences growing?
Revenue grew 22.9% a year on average over the last five fiscal years, from $27.6 million to $77.4 million.
What are Sight Sciences's earnings per share?
Sight Sciences earned $-0.75 per diluted share in fiscal 2025, compared with $-0.99 a year earlier.
When will Sight Sciences report its next earnings?
Sight Sciences is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.
When does Sight Sciences's fiscal year end?
Sight Sciences's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 4, 2026.